Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Eugene Shenderov, Angelo M. De Marzo, Tamara L. Lotan, Hao Wang, Sin Chan, Su Jin Lim, Hongkai Ji, Mohamad E. Allaf, Carolyn Chapman, Paul A. Moore, Francine Chen, Kristina Sorg, Andrew M. White, Sarah E. Church, Briana Hudson, Paul A. Fields, Shaohui Hu, Samuel R. Denmeade, Kenneth J. Pienta, Christian P. PavlovichAshley E. Ross, Charles G. Drake, Drew M. Pardoll, Emmanuel S. Antonarakis

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science